Molecular characterization of prostatic small-cell neuroendocrine carcinoma

Prostate

Volumn 55, Issue 1, 2003, Pages 55-64

  Clegg, Nigel ^a   Ferguson, Camari ^a   True, Lawrence D ^a   Arnold, Hugh ^a   Moorman, Alec ^a   Quinn, Janna E ^a   Vessella, Robert L ^a   Nelson, Peter S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

cDNA; Database; Digital expression; Expressed sequence tag; Xenograft

Indexed keywords

CD24 ANTIGEN; ENOLASE; MOLECULAR MARKER; SECRETOGRANIN II; SYNAPTOPHYSIN;

AGED; ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; DNA LIBRARY; DNA SEQUENCE; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NEUROSECRETORY CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SEQUENCE ANALYSIS; SMALL CELL CARCINOMA; UPREGULATION; XENOGRAFT;

AGED; ANIMALS; BLOTTING, NORTHERN; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CLUSTER ANALYSIS; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0037384465     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10217     Document Type: Article

References (55)

1. di Sant'Agnese P, de Mesy Jensen K. Endocrine-paracrine cells of the prostate and prostatic urethra; an ultrastructural study. Hum Pathol 1984;15:1034-1041.
2. di Sant'Agnese P, de Mesy Jensen K. Human prostatic endocrine-paracrine (APUD) cells: Distributional analysis with a comparison of serotonin and neuron specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 1985;109:607-612.
3. di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992;23:287-296.
4. di Sant'Agnese PA. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: A review of morphologic aspects. Urology 1998;51(Suppl 5A):121-124.
5. Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status. The Prostate 1998;36(Suppl 8):18-22.
6. Abrahamsson PA. Neuroendocrine cells in tumor growth of the prostate. Endocrine-Related Cancer 1999;6:503-519.
7. di Sant'Agnes PA, Cockett ATK. Neuroendocrine differentiation in prostatic malignancy. Cancer 1996;78:357-361.
8. Cohen RJ, Glezerson G, Haffejee Z. Prostatic carcinoma. Histological and immuno-histological factors affecting prognosis. Br J Urol 1991;66:405-410.
9. di Sant'Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate: Diagnostic, prognostic, and therapeutic implications. Cancer 1992;70:254-258.
10. Skalnik DG, Dorfman DM, Williams DA, Orkin SH. Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol Cell Biol 1991;11:4518-4527.
11. Perez-Stable C, Altman NH, Brown J, Harbison M, Cray C, Roos BA. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Lab Invest 1996;74:363-373.
12. Perez-Stable C, Altman NH, Mehta PP, Deftos LJ, Roos BA. Prostate cancer progression, metastasis, and gene expression in transgenic mice. Cancer Res 1997;57:900-906.
13. Garabedian EM, Humphrey PA, Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci USA 1998;95:15382-15387.
14. DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L, Moats S, Ramirez A, Jorcano J, Conti C. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 2000;97:3455-3460.
15. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 2001;61:2239-2249.
16. Jongsma J, Oomen MH, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schroder FH, van Steenbrugge GJ. Androgen deprivation of the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiation. Cancer Res 2000;60:741-748.
17. Jelbart ME, Russell PJ, Fullerton M. Ectopic hormone production by a prostatic small-cell carcinoma xenograft line. Mol Cell Endocrinol 1988;55:161-171.
18. Pinthus JH, Waks T, Schindler DG, Harmelin A, Said JW, Bellegrun A, Ramon J, Eshhar Z. WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma. Cancer Res 2000;60:6563-6567.
19. True LD, Buhler K, Quinn J, Williams E, Nelson P, Clegg N, Macoska J, Norwood T, Liu A, Ellis W, Lange P, Vessella R. A neuroendocrine/small cell prostate carcinoma xenograft: LuCaP 49. Am J Pathol 2002;705-715.
20. Buhler K, Quinn J, Whitney S, Lin D, Ellis W, Corey E, Liu A, True L, Lange P, Vessella R. The LuCaP series of human prostate cancer xenografts. J Urol 1999;161:58.
21. Nelson PS, Ng WL, Schummer M, True LD, Liu AY, Bumgarner RE, Ferguson C, Dimak A, Hood L. An expressed-sequence-tag database of the human prostate: Sequence analysis of 1168 cDNA clones. Genomics 1998;47:12-25.
22. Clegg N, Eroglu B, Ferguson C, Arnold A, Moorman A, Nelson PS. Digital expression profiles of the androgen response program. J Steroid Biochem Mol Biol 2002;80:13-23.
23. Hawkins V, Doll D, Bumgarner R, Smith T, Abajian C, Hood L, Nelson PS. PEDB: The Prostate Expression Database. Nucleic Acids Res 1999;27:204-208.
24. Nelson PS, Pritchard C, Eroglu B, Abott D, Clegg N. The human (PEDB) and mouse (mPEDB) prostate expression databases. Nucleic Acids Res 2002;30:218-220.
25. Schuler GD. Pieces of the puzzle: Expressed sequence tags and the catalog of human genes. J Mol Med 1997;75:694-698.
26. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA, Wheeler DL. GenBank. Nucleic Acids Res 2000;28:15-18.
27. Boguski MS, Lowe TM, Tolstoshev CM. dbEST-database for expressed sequence tags. Nat Genet 1993;4:332-333.
28. Adams MD, Kerlavage AR, Fleischman RD. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995; 377(Suppl 28):3-174.
29. Audic S, Claverie JM. The significance of digital gene expression profiles. Genome Res 1997;7:986-995.
30. Hastie ND, Bishop JO. The expression of three abundance classes of messenger RNA in mouse tissue. Cell 1976;9:761-774.
31. Tooze SA, Martens GJM, Huttner WB. Secretory granule biogenesis: Rafting to the SNARE. Trends Cell Biol 2001;11:116-122.
32. Kim T, Tao-Cheng J-H, Eiden LE, Loh YP. Chromogranin A, an On/Off switch controlling dense-core secretory granule biogenesis. Cell 2001;106:499-509.
33. Weiss U, Ischia R, Eder S, Lovisetti-Scamihorn P, Bauer R, Fischer-Colbrie R. Neuroendocrine secretory protein 55 (NESP55): Alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein. Neuroendocrinology 2000;71:177-186.
34. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M, Nelkin BD. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 1993;90:5648-5652.
35. Borges M, Linnoila RI, van de Velde HJK, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997;386:852-855.
36. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. The Prostate 1996;28:98-106.
37. Xue Y, Smedts F, Verhofstad A, Debruyne F, de la Rosette J, Schalken J. Cell kinetics of prostate exocrine neuroendocrine epithelium and their differential interrelationship: New perspectives. The Prostate 1998;36(Suppl 8):62-73.
38. de Marzo AM, Nleson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998;160:2381-2392.
39. Aumuller G, Leonhardt M, Janssen M, Konrad L, Bjartell A, Abrahamsson PA. Neurogenic origin of human prostate endocrine cells. Urology 1999;53:1041-1048.
40. Chan SO, Chiu FC. Cloning and developmental expression of human 66 kD neurofilament protein. Brain Res Mol Brain Res 1995;29:177-184.
41. Moreira EF, Jaworski CJ, Rodriguez IR. Cloning of a novel member of the reticulon gene family (RTN3): Gene structure and chromosomal localization to 11q13. Genomics 1999;58:73-81.
42. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434-439.
43. GrandePre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000;403:439-444.
44. von Poser C, Sudhof TC. Synaptotagmin 13: Structure and expression of a novel synaptotagmin. Eur J Cell Biol 2001;80:41-47.
45. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991;67:423-435.
46. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991;353:529-536.
47. Kidd T, Brose K, Mitchell KJ, Fetter RD, Tessier-Lavigne M, Goodman CS, Tear G. Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 1998;92:205-215.
48. Tse W, Zhu W, Chen HS, Cohen A. A novel gene, AF1q, fused to MLL in t(1;11)(q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 1995;85:650-656.
49. Tewari M, Yu M, Ross B, Dean C, Giordano A, Rubin R. AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res 1997;57:4063-4069.
50. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999;13:1924-1935.
51. Yarden RI, Brody LC. BRCA1 interacts with components of the histone deacetylase core complex. Proc Natl Acad Sci USA 1999;96:4983-4988.
52. Bang Y-J, Pirnia F, Fang W-G. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci USA 1994;91:5330-5334.
53. Cox ME, Deeble PD, Lakhani S, Parsons SJ. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression. 1999;59:3821-3830.
54. Burchardt T, Burchardt M, Chen MW, Cao Y, de la Taille A, Shabsigh A, Hayek O, Dorai T, Buttyan R. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol 1999;162:1800-1805.
55. Stein CA. Mechanisms of action of taxanes in prostate cancer. Seminars in Oncology 1999;26(Suppl 17):3-7.